2007Expert Review of Obstetrics & GynecologyRequires access

Famciclovir for recurrent genital herpes

Alejandra Varela, Anita Arora, Natalia Mendoza, Daniel Carrasco, Stephen K. Tyring

Open publisher page 0 citations

Abstract

Recurrent genital herpes is a significant problem for patients worldwide. Not only is the infection painful, but patients are affected by its emotional and psychological burden. Famciclovir, an orally administered prodrug of the antiviral agent penciclovir, is an excellent option for patients with recurrent genital herpes. While genital herpes has no cure, infected patients can treat their outbreaks episodically or they can choose suppressive therapy. Famciclovir can be used in both cases. Famciclovir has a safety profile that is comparable to placebo, acyclovir and valacyclovir, and is the only oral antiviral that has been proven effective to date in preventing a full herpes outbreak using a single-day treatment.

About this research paper

What this paper is about

Recurrent genital herpes is a significant problem for patients worldwide. Not only is the infection painful, but patients are affected by its emotional and psychological burden. Famciclovir, an orally administered prodrug of the antiviral agent penciclovir, is an excellent option for patients with recurrent genital herpes. While genital herpes has no cure, infected patients can treat their outbreaks episodically or they can choose suppressive therapy. Famciclovir can be used in both cases. Famciclovir has a safety profile that is comparable to placebo, acyclovir and valacyclovir, and is the only oral antiviral that has been proven effective to date in preventing a full herpes outbreak using a single-day treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Recurrent genital herpes is a significant problem for patients worldwide. Not only is the infection painful, but patients are affected by its emotional and psychological burden. Famciclovir, an orally administered prodrug of the antiviral agent penciclovir, is an excellent option for patients with recurrent genital herpes. While genital herpes has no cure, infected patients can treat their outbreaks episodically or they can choose suppressive therapy. Famciclovir can be used in both cases. Famciclovir has a safety profile that is comparable to placebo, acyclovir and valacyclovir, and is the only oral antiviral that has been proven effective to date in preventing a full herpes outbreak using a single-day treatment.

Key concepts: Famciclovir, Medicine, Penciclovir, Genital herpes, Valaciclovir, Dermatology, Sex organ, Outbreak

Related papers

Back to paper searchBrowse research topicsOriginal source
Famciclovir for recurrent genital herpes — Research Paper | ScholarLens